SSPL Securities Private Limited

Monday 16 Jun, 2025 09:25 AM

Site map | Locate Us | Login

Aurobindo Pharma's US arm incorporates Cresedemo Pharma Lemon Tree Hotels signs new property in Arunachal Pradesh Adani Enterprises arm incorporates wholly owned subsidiary Syngene's Bengaluru-based facility gets 'NAi' status from US FDA NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit Arkade Developers acquires 6.28 acre land in Thane; targets Rs 2000 cr GDV NTPC to raise Rs 4,000 cr via 10-Year NCDs at 6.89% Diamond Power Infra secures new orders worth Rs 117-cr RPP Infra gains on bagging Rs 283-cr LoA from UPSIDA Kanpur GTL Infrastructure Ltd leads losers in 'A' group Balu Forge Industries Ltd leads losers in 'B' group Coal India sets up CIL Rajasthan Akshay Urja subsidiary for renewable energy Jyoti Resins incorporates new WOS, Jyoti Social Welfare Foundation Volumes soar at Jubilant Ingrevia Ltd counter Crisil Ratings reaffirms 'A/A1+' ratings of Heranba Industries with 'stable' outlook

Saravan Stocks

«« +1

««-1

Profit and Loss


Biocon Ltd	Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code	ISIN Demat	Book Value(R)	NSE Symbol	Div & Yield %	Market Cap (Rs.Cr)	P/E(TTM)	EPS(TTM)	Face Value(R)
532523	INE376G01013	95.9811761	BIOCON	0.35	42675.33	0	0.41	5

	Mar 2024 (Rs.Cr)	Mar 2023 (Rs.Cr)	Mar 2022 (Rs.Cr)	Mar 2021 (Rs.Cr)	Mar 2020 (Rs.Cr)	Mar 2019 (Rs.Cr)
INCOME :
Sales Turnover	2127.30	1992.90	1738.20	2028.40	1988.40	1785.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2127.30	1992.90	1738.20	2028.40	1988.40	1785.70
Other Income	207.50	3134.20	187.20	150.20	366.00	422.00
Stock Adjustments	99.10	-3.20	105.80	-36.70	31.40	69.10
Total Income	2433.90	5123.90	2031.20	2141.90	2385.80	2276.80
EXPENDITURE :
Raw Materials	1033.80	981.00	914.00	761.60	859.10	857.60
Power & Fuel Cost	215.30	279.20	231.00	186.00	193.30	152.40
Employee Cost	452.30	433.80	367.70	390.20	344.80	289.10
Other Manufacturing Expenses	155.40	127.10	130.50	147.00	118.30	104.30
Selling & Administrative Expenses	135.00	112.20	106.70	128.40	208.40	222.40
Miscellaneous Expenses	-28.10	32.90	33.00	66.00	9.90	18.70
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1963.70	1966.20	1782.90	1679.20	1733.80	1644.50
Operating Profit	470.20	3157.70	248.30	462.70	652.00	632.30
Interest	198.80	69.60	0.40	0.40	1.20	2.60
Gross Profit	271.40	3088.10	247.90	462.30	650.80	629.70
Depreciation	121.10	116.90	108.20	103.50	98.00	92.30
Profit Before Tax	150.30	2971.20	139.70	358.80	552.80	537.40
Tax	15.10	132.70	60.70	73.50	104.40	54.60
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	15.90	-9.90	-7.10	4.80	7.50	-9.90
Reported Net Profit	119.30	2848.40	86.10	280.50	440.90	492.70
Extraordinary Items	13.41	2861.73	2.92	3.00	136.27	166.64
Adjusted Net Profit	105.89	-13.33	83.18	277.50	304.63	326.06
Adjustment below Net Profit	30.70	29.40	-59.40	30.40	22.60	-51.80
P & L Balance brought forward	9950.60	7132.80	7106.10	6795.20	6391.80	6020.60
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	180.10	60.00	0.00	0.00	60.10	69.40
P & L Balance carried down	9920.50	9950.60	7132.80	7106.10	6795.20	6392.10
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	30.00	10.00	0.00	0.00	20.00
Dividend Per Share(Rs)	0.50	1.50	0.50	0.00	0.00	1.00
Earnings Per Share-Unit Curr	0.99	23.72	0.72	2.34	3.67	8.21
Earnings Per Share(Adj)-Unit Curr	0.99	23.72	0.72	2.34	3.67	4.11
Book Value-Unit Curr	90.88	90.91	67.40	65.88	62.80	118.58
Book Value(Adj)-Unit Curr	90.88	90.91	67.40	65.88	62.80	59.29

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure

Hit Count : 41980817

Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR

SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)

© Copyright 2011 All Rights Reserved. SSPL Securities Private Limited